Table 2.
Univariate and multivariate Cox regression analysis for all-cause mortality
| Variables | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
| HR | 95%CI | P value | HR | 95%CI | P value | |
| Age | 1.084 | 1.059–1.110 | < 0.001 | 1.089 | 1.060–1.119 | < 0.001 |
| Smoker | 1.439 | 1.031–2.009 | 0.032 | 1.575 | 1.104–2.246 | 0.012 |
| Hypertension | 2.436 | 1.347–4.404 | 0.003 | |||
| Previous MI | 1.649 | 1.105–2.459 | 0.014 | |||
| Previous stroke | 1.563 | 1.099–2.223 | 0.013 | |||
| ACS | 1.310 | 0.870–1.973 | 0.196 | 1.801 | 1.125–2.883 | 0.014 |
| LVEF | 0.953 | 0.939–0.968 | < 0.001 | 0.962 | 0.943–0.982 | < 0.001 |
| Hemoglobin | 0.990 | 0.984–0.997 | 0.006 | |||
| SHR | 1.993 | 1.492–2.664 | < 0.001 | 2.171 | 1.566–3.008 | < 0.001 |
| TC | 0.866 | 0.754–0.995 | 0.042 | |||
| TG | 0.849 | 0.698–1.032 | 0.100 | |||
| HDL-C | 0.601 | 0.331–1.091 | 0.094 | |||
| LDL-C | 0.865 | 0.731–1.022 | 0.088 | |||
| hs-CRP | 1.007 | 1.003–1.011 | 0.011 | |||
| NT-proBNP (per 100 pg/ml) | 1.011 | 1.008–1.013 | < 0.001 | 1.005 | 1.001–1.009 | 0.009 |
|
Creatinine Three-vessel disease |
1.007 1.507 |
1.004–1.010 0.983–2.309 |
< 0.001 | |||
| 0.060 | ||||||
| Left main disease | 1.666 | 1.094–2.537 | 0.017 | 1.626 | 1.045–2.532 | 0.031 |
| Aspirin | 0.456 | 0.213–0.975 | 0.043 | |||
| Statin | 0.452 | 0.244–0.837 | 0.012 | 0.494 | 0.248–0.982 | 0.044 |
MI myocardial infarction, ACS acute coronary syndrome, LVEF left ventricle ejection fraction, SHR stress hyperglycemia ratio, TC total cholesterol, TG triglycerides, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, hs‐CRP high‐sensitivity C‐reactive protein, NT-proBNP N-terminal proB-type natriuretic peptide, HR hazard ratio, CI confidential interval